<DOC>
	<DOCNO>NCT02035111</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Tianshu capsule treat Migraine Headache .</brief_summary>
	<brief_title>A Randomized , Placebo-Controlled , Double-blind Study Tianshu Capsule Treatment Migraine .</brief_title>
	<detailed_description>Primary headache disorder , particularly migraine globally prevalent . Many study show burden impose : pain , disability , reduce quality life ( QoL ) , mark impairment participation work social activity , heavy financial cost . The purpose study evaluate safety efficacy Tianshu capsule treat Migraine Headache . To provide safe effective treatment Migraine Headache .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Must meet Migraine diagnosis . Age onset age 50 year . Migraine must occur 1 year precede entry trial . The number migraine attack le 6 period 3 month prior Screening stage . The number migraine day 28 period 1 month prior screen entry trial . Migraine day less 15 period 1 month prior screen entry trial . Ages 1865 . Participant understand complete Headache diary . All participant sign informed consent . Other migraine prophylactic medication continue 3 month prior drug trial . Participants take Tianshu capsule 1 month prior Screening stage . The number acute treatment migraine 10 per month . Participants take antipsychotic antidepressant medication ( unless migraine prophylaxis ) previous 3 month . Participants abuse alcohol drug . Participants resistant acute migraine drug prescribe optimally . hypotension uncontrolled hypertension . Severe infection . Malignancy . Significant medical history cardiac disease , cerebrovascular disease , liver disease , nephropathy etc . Known allergies serious side effect Tianshu capsule past . Breastfeeding , pregnant potentially fertile woman participant . History cluster headache , tensiontype headache , vascular headache nonmigraine , drug dependence headache . Secondary headache , include hypertension , posttraumatic brain syndrome etc . Participants take migraine prophylactic medication regularly 1 month prior Screening stage . Participants take part clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Tianshu capsule</keyword>
</DOC>